GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LigaChem Biosciences Inc (XKRX:141080) » Definitions » Cyclically Adjusted Book per Share

LigaChem Biosciences (XKRX:141080) Cyclically Adjusted Book per Share : ₩5,580.72 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is LigaChem Biosciences Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

LigaChem Biosciences's adjusted book value per share for the three months ended in Mar. 2024 was ₩17,460.339. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩5,580.72 for the trailing ten years ended in Mar. 2024.

During the past 12 months, LigaChem Biosciences's average Cyclically Adjusted Book Growth Rate was 18.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-08), LigaChem Biosciences's current stock price is ₩69000.00. LigaChem Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₩5,580.72. LigaChem Biosciences's Cyclically Adjusted PB Ratio of today is 12.36.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of LigaChem Biosciences was 15.35. The lowest was 6.83. And the median was 9.10.


LigaChem Biosciences Cyclically Adjusted Book per Share Historical Data

The historical data trend for LigaChem Biosciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LigaChem Biosciences Cyclically Adjusted Book per Share Chart

LigaChem Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 4,560.46 5,146.37

LigaChem Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,695.05 4,856.02 5,055.95 5,146.37 5,580.72

Competitive Comparison of LigaChem Biosciences's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, LigaChem Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LigaChem Biosciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LigaChem Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where LigaChem Biosciences's Cyclically Adjusted PB Ratio falls into.



LigaChem Biosciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, LigaChem Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=17460.339/118.8477*118.8477
=17,460.339

Current CPI (Mar. 2024) = 118.8477.

LigaChem Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 1,037.739 99.353 1,241.361
201409 962.210 99.608 1,148.065
201412 1,308.948 99.098 1,569.814
201503 0.000 99.720 0.000
201506 0.000 100.050 0.000
201509 0.000 100.110 0.000
201512 2,386.944 100.220 2,830.601
201603 2,293.322 100.560 2,710.382
201606 2,325.526 100.790 2,742.171
201609 3,422.741 101.460 4,009.313
201612 3,020.778 101.560 3,534.979
201703 2,853.973 102.850 3,297.891
201706 2,747.478 102.610 3,182.257
201709 2,652.016 103.490 3,045.570
201712 2,421.314 102.990 2,794.131
201803 2,913.669 104.100 3,326.444
201806 2,873.505 104.130 3,279.645
201809 2,572.586 105.650 2,893.951
201812 4,766.833 104.350 5,429.105
201903 4,758.632 104.490 5,412.503
201906 4,669.047 104.880 5,290.861
201909 5,453.023 105.200 6,160.449
201912 5,274.519 105.120 5,963.322
202003 5,167.858 105.540 5,819.481
202006 4,894.137 104.870 5,546.457
202009 4,676.869 106.200 5,233.852
202012 4,725.378 105.765 5,309.868
202103 4,080.901 107.357 4,517.682
202106 3,472.555 107.579 3,836.313
202109 9,779.285 108.759 10,686.411
202112 10,615.606 109.676 11,503.298
202203 10,260.194 111.806 10,906.415
202206 10,019.001 114.083 10,437.465
202209 9,937.237 114.831 10,284.807
202212 8,568.249 115.200 8,839.539
202303 7,617.248 116.550 7,767.443
202306 6,948.366 117.140 7,049.667
202309 6,146.293 119.111 6,132.696
202312 5,291.959 118.848 5,291.959
202403 17,460.339 118.848 17,460.339

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


LigaChem Biosciences  (XKRX:141080) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

LigaChem Biosciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=69000.00/5580.72
=12.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of LigaChem Biosciences was 15.35. The lowest was 6.83. And the median was 9.10.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


LigaChem Biosciences Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of LigaChem Biosciences's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


LigaChem Biosciences (XKRX:141080) Business Description

Traded in Other Exchanges
N/A
Address
8-26 Munpyeongseo-ro, Daedeok-gu, Daejeon, KOR, 34302
LegoChem Biosciences Inc develops new drugs through research. The Company provides business research services, manufacturing and sale of compounds, and drug evaluation.

LigaChem Biosciences (XKRX:141080) Headlines

No Headlines